BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31145312)

  • 1. The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study.
    Song WC; Wang XF; Lv WW; Xu XY; Tian M
    Medicine (Baltimore); 2019 May; 98(22):e15807. PubMed ID: 31145312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
    Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
    Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
    Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
    Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection.
    Kakushima N; Fujishiro M; Yahagi N; Kodashima S; Nakamura M; Omata M
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1586-9. PubMed ID: 16928221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
    Takahashi Y; Takeuchi T; Kojima Y; Nagami Y; Ominami M; Uedo N; Hamada K; Suzuki H; Oda I; Miyaoka Y; Yamanouchi S; Tokioka S; Tomatsuri N; Yoshida N; Naito Y; Nonaka T; Kodashima S; Ogata S; Hongo Y; Oshima T; Li Z; Shibagaki K; Oikawa T; Tominaga K; Higuchi K
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1341-1346. PubMed ID: 29265496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
    Tulassay Z; Kryszewski A; Dite P; Kleczkowski D; Rudzinski J; Bartuzi Z; Hasselgren G; Larkö A; Wrangstadh M
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1457-65. PubMed ID: 11742194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial.
    Kim SG; Song HJ; Choi IJ; Cho WY; Lee JH; Keum B; Lee YC; Kim JG; Park SK; Park BJ; Jung HC;
    Dig Liver Dis; 2013 May; 45(5):385-9. PubMed ID: 23333104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
    Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
    Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between
    Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
    World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
    Medeiros JA; Gonçalves TM; Boyanova L; Pereira MI; de Carvalho JN; Pereira AM; Cabrita AM
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):555-9. PubMed ID: 21207091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of rifampicin-based rescue therapy for Helicobacter pylori eradication failure in peptic ulcer disease.
    Ahuja V; Bhatia V; Dattagupta S; Raizada A; Sharma MP
    Dig Dis Sci; 2005 Apr; 50(4):630-3. PubMed ID: 15844693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study.
    Higuchi K; Takeuchi T; Uedo N; Takeuchi Y; Naito Y; Yagi N; Tominaga K; Machida H; Tamada T; Morita Y; Yazumi S; Yamao J; Iguchi M; Azuma T
    Gastric Cancer; 2015 Jul; 18(3):612-7. PubMed ID: 25098924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.